4.5 Article

Glutathione disulfide and S-nitrosoglutathione detoxification by Mycobacterium tuberculosis thioredoxin system

期刊

FEBS LETTERS
卷 583, 期 19, 页码 3215-3220

出版社

WILEY
DOI: 10.1016/j.febslet.2009.09.007

关键词

Mycobacteria; Tuberculosis; Thioredoxin; Glutathione; S-nitrosoglutathione; Mycothiol

资金

  1. TB VETS Charitable foundation
  2. Pacific Century Graduate Scholarship
  3. University of British Columbia Graduate Fellowship

向作者/读者索取更多资源

Mycobacterium tuberculosis resides within alveolar macrophages. These phagocytes produce reactive nitrogen and oxygen intermediates to combat the invading pathogens. The macrophage glutathione (GSH) pool reduces nitric oxide (NO) to S-nitrosoglutathione (GSNO). Both glutathione disulfide (GSSG) and GSNO possess mycobactericidal activities in vitro. In this study we demonstrate that M. tuberculosis thioredoxin system, comprises of thioredoxin reductase B2 and thioredoxin C reduces the oxidized form of the intracellular mycothiol (MSSM) and is able to efficiently reduce GSSG and GSNO in vitro. Our study suggests that the thioredoxin system provide a general reduction mechanism to cope with oxidative stress associated with the microbe's metabolism as well as to detoxify xenobiotics produced by the host. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

THP-1 and Dictyostelium Infection Models for Screening and Characterization of Anti-Mycobacterium abscessus Hit Compounds

Adrian Richter, Tirosh Shapira, Yossef Av-Gay

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Chemistry, Multidisciplinary

DMN-Tre Labeling for Detection and High-Content Screening of Compounds against Intracellular Mycobacteria

Henok A. Sahile, Celine Rens, Tirosh Shapira, Raymond J. Andersen, Yossef Av-Gay

ACS OMEGA (2020)

Article Chemistry, Medicinal

MymA Bioactivated Thioalkylbenzoxazole Prodrug Family Active against Mycobacterium tuberculosis

Abraham L. Moure, Gagandeep Narula, Flavia Sorrentino, Adama Bojang, Clement K. M. Tsui, Carine Sao Emani, Esther Porras-De Francisco, Beatriz Diaz, Maria Jose Rebollo-Lopez, Pedro Alfonso Torres-Gomez, Eva Maria Lopez-Roman, Isabel Camino, Patricia Casado Castro, Laura Guijarro Lopez, Faprimetima Ortega, Lluis Ballell, David Barros-Aguirre, Modesto Remuinan Blanco, Yossef Av-Gay

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Microbiology

High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity AgainstMycobacterium tuberculosis

Tirosh Shapira, Leah Rankine-Wilson, Joseph D. Chao, Virginia Pichler, Celine Rens, Tom Pfeifer, Yossef Av-Gay

FRONTIERS IN MICROBIOLOGY (2020)

Review Immunology

BCG immunomodulation: From the 'hygiene hypothesis' to COVID-19

Aaron J. Moulson, Yossef Av-Gay

Summary: The century-old BCG vaccine has gained renewed interest for its ability to protect against various non-TB pathogens, with potential for use as an immunotherapeutic agent for autoimmune, allergic, neurodegenerative, and neoplastic diseases as well as a preventive measure against infections. Particularly noteworthy is its proposed use in countering the rise of autoimmune and allergic conditions, as well as its potential in mitigating the spread of COVID-19 until a specific vaccine is developed.

IMMUNOBIOLOGY (2021)

Review Microbiology

Roles for phthiocerol dimycocerosate lipids in Mycobacterium tuberculosis pathogenesis

Celine Rens, Joseph D. Chao, Danielle L. Sexton, Elitza Tocheva, Yossef Av-Gay

Summary: PDIMs are complex lipids found in the cell envelope of Mycobacterium tuberculosis that play a key role in the pathogenesis of the bacterium, particularly in bacterial virulence and in association with the ESX-1 secretion system. However, the mechanisms by which PDIMs help M. tuberculosis to control macrophage phagocytosis, inhibit phagosome acidification and modulate host innate immunity are still not fully understood.

MICROBIOLOGY-SGM (2021)

Review Microbiology

From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis

Leah Isobella Rankine-Wilson, Tirosh Shapira, Carine Sao Emani, Yossef Av-Gay

Summary: Tuberculosis, caused by Mycobacterium tuberculosis, is a serious disease that requires lengthy and complicated treatment. Understanding the physiological mechanisms of Mtb can lead to the development of more effective drug therapies.

MICROBIOLOGY-SGM (2021)

Editorial Material Microbiology

Editorial: New Approaches Against Drug-Resistant M. tuberculosis

Yossef Av-Gay, Giorgia Mori, Maria Rosalia Pasca

FRONTIERS IN MICROBIOLOGY (2021)

Article Biochemical Research Methods

Apoptosis assessment in high-content and high-throughput screening assays

Celine Rens, Tirosh Shapira, Sandra Pena-Diaz, Joseph D. Chao, Tom Pfeifer, Yossef Av-Gay

Summary: The authors developed AUTOptosis, a cost-effective and rapid apoptosis monitoring method based on quantifying nuclei intensity via staining with Hoechst 33342. They calibrated the method with standard apoptosis inducers in multiple cell lines, validated its applicability for high-content screening using a compound library, and demonstrated its specificity by detecting apoptosis triggered by Mycobacterium tuberculosis infections. AUTOptosis method involves morphological analysis of nuclear condensation during caspase-3-dependent apoptosis, where Hoechst-stained nuclei appear brighter during apoptosis and fade during necrosis, providing an apoptosis index for comparing test and control conditions.

BIOTECHNIQUES (2021)

Article Chemistry, Medicinal

Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis

Adrian Richter, Gagandeep Narula, Ines Rudolph, Ruediger W. Seidel, Christoph Wagner, Yossef Av-Gay, Peter Imming

Summary: 8-Nitrobenzothiazinones (BTZs) are a promising class of antimycobacterial agents currently being investigated in clinical trials. A new synthetic pathway has been established to synthesize various analogues of BTZs, allowing the replacement of the sulphur atom by oxygen or nitrogen. A total of 36 analogues were synthesized and tested for their potential activity against Mycobacterium tuberculosis (Mtb) in in vitro assays.

CHEMMEDCHEM (2022)

Article Biotechnology & Applied Microbiology

Screening of diverse marine invertebrate extracts identified Lissoclinotoxin F, Discodermin B, and other anti-Mycobacterium tuberculosis active compounds

Henok A. Sahile, David E. Williams, Nicole J. de Voogd, Mary Ko, Raymond J. Andersen, Yossef Av-Gay

Summary: Screening and isolation of marine derived crude natural products led to the discovery of 10 hits with activity against Mycobacterium tuberculosis (Mtb). Among them, lissoclinotoxin F (1) showed the highest potency and selectivity, and could be a potential lead compound for the development of new TB drugs.

JOURNAL OF ANTIBIOTICS (2022)

Article Biochemistry & Molecular Biology

Hit Compounds and Associated Targets in Intracellular Mycobacterium tuberculosis

Clement K. M. Tsui, Flavia Sorrentino, Gagandeep Narula, Alfonso Mendoza-Losana, Ruben Gonzalez del Rio, Esther Perez Herran, Abraham Lopez, Adama Bojang, Xingji Zheng, Modesto Jesus Remuinan-Blanco, Yossef Av-Gay

Summary: Through chemical-genetic characterization and whole genome sequencing analysis, novel drug targets and drug resistance genes associated with Mycobacterium tuberculosis (Mtb) intracellular growth were identified. The exploration of Mtb chemical mutant genomes could aid in novel drug discovery and the understanding of tuberculosis treatment mechanisms.

MOLECULES (2022)

Article Multidisciplinary Sciences

Whole blood RNA-seq demonstrates an increased host immune response in individuals with cystic fibrosis who develop nontuberculous mycobacterial pulmonary disease

Miguel Dario Prieto, Jiah Jang, Alessandro N. Franciosi, Yossef Av-Gay, Horacio Bach, Scott J. Tebbutt, Bradley S. Quon

Summary: This study found that patients with cystic fibrosis who develop non-tuberculous mycobacteria pulmonary disease (NTM-PD) exhibit enhanced innate immune responses, which is different from the non-cystic fibrosis population.

PLOS ONE (2022)

Article Biochemistry & Molecular Biology

Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication

Tirosh Shapira, Selvarani Vimalanathan, Celine Rens, Virginia Pichler, Sandra Pena-Diaz, Grace Jordana, William Rees, Dirk F. H. Winkler, Iqbal Sarai, Theodore Steiner, Francois Jean, Steven Pelech, Yossef Av-Gay

Summary: GSK3 beta inhibitors have shown broad-spectrum anti-coronaviridae activity, including against SARS-CoV-2, with low toxicity to host cells. A lead compound, T-1686568, exhibited dose-dependent activity against SARS-CoV-2 and HCoV-229E and showed efficacy in viral-infected cells and organoids. GSK3 beta and PKCa can phosphorylate the nucleocapsid protein of SARS-CoV-2, inhibiting its translation.

MOLECULAR BIOMEDICINE (2022)

Article Biochemistry & Molecular Biology

Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and target Pik1

Rosanne Persaud, Sheena C. Li, Joseph D. Chao, Roberto Forestieri, Elizabeth Donohue, Aruna D. Balgi, Xingji Zheng, Jesse T. Chao, Yoko Yashiroda, Mami Yoshimura, Christopher J. R. Loewen, Anne-Claude Gingras, Charles Boone, Yossef Av-Gay, Michel Roberge, Raymond J. Andersen

Summary: A study found that the marine natural product clionamines can activate autophagy and inhibit the survival of Mycobacterium tuberculosis in macrophages. Pik1 was identified as the target protein of clionamines using a yeast chemical-genetics approach. Further research revealed that PI4KB is an unexploited molecular target that, when knocked down, can inhibit the survival of Mycobacterium tuberculosis in macrophages.

CELL CHEMICAL BIOLOGY (2022)

暂无数据